This newslink doesn't exist or it was removed.
Go to Homempage.
RTTNews USA Health April 19, 2023
The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA vaccines of ModernaTX Inc. and Pfizer-BioNTech to simplify the vaccination schedule for most individuals.With the changes, the current bivalent vaccines,... + más
FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines | RTTNews
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
Ars Technica USA Science June 07, 2023
Navigate Filter by topic Settings Front page layout Site theme - Jun 6, 2023 9:24 pm UTC / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. The Food and Drug Administration has withdrawn authorization for Johnson & Johnson's... + más
What Are the Duties of A Trustee? | Forbes
NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN
Politico USA Health October 15, 2022
Biden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
ABC7 USA Health October 18, 2022
in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
About iurex | Privacy Policy | Disclaimer |